|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating Expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total Operating Expenses | |||||
| Loss From Operations | |||||
| Other Income (Expense): | |||||
| Interest income, net | |||||
| Grant income | |||||
| Other income | |||||
| Gain on exchange of warrants | |||||
| Change in fair value of warrant liabilities | |||||
| Total Other Income | |||||
| Net Loss | |||||
| Net Loss Per Share - Basic | |||||
| Net Loss Per Share - Diluted | |||||
| Weighted Average Common Shares Outstanding - Basic | |||||
| Weighted Average Common Shares Outstanding - Diluted | |||||
Loading...